Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy

Abstract

Development of drug resistance represents the major cause of cancer therapy failure, determines disease progression and results in poor prognosis for cancer patients. Different mechanisms are responsible for drug resistance. Intrinsic genetic modifications of cancer cells induce the alteration of expression of gene controlling specific pathways that regulate drug resistance: drug transport and metabolism; alteration of drug targets; DNA damage repair; and deregulation of apoptosis, autophagy, and pro-survival signaling. On the other hand, a complex signaling network among the entire cell component characterizes tumor microenvironment and regulates the pathways involved in the development of drug resistance. Gut microbiota represents a new player in the regulation of a patient’s response to cancer therapies, including chemotherapy and immunotherapy. In particular, commensal bacteria can regulate the efficacy of immune checkpoint inhibitor therapy by modulating the activation of immune responses to cancer. Commensal bacteria can also regulate the efficacy of chemotherapeutic drugs, such as oxaliplatin, gemcitabine, and cyclophosphamide. Recently, it has been shown that such bacteria can produce extracellular vesicles (EVs) that can mediate intercellular communication with human host cells. Indeed, bacterial EVs carry RNA molecules with gene expression regulatory ability that can be delivered to recipient cells of the host and potentially regulate the expression of genes involved in controlling the resistance to cancer therapy. On the other hand, host cells can also deliver human EVs to commensal bacteria and similarly, regulate gene expression. EV-mediated intercellular communication between commensal bacteria and host cells may thus represent a novel research area into potential mechanisms regulating the efficacy of cancer therapy.

Keywords

Gut microbiota / resistance / chemotherapy / immunotherapy / immune checkpoint inhibitor / extracellular vesicles / miRNAs / cell-to-cell communication

References

[1] Housman G,Heerboth S,Longacre M.Drug resistance in cancer: an overview..Cancers (Basel)2014;6:1769-92 PMCID:PMC4190567

[2] Dean M,Bates S.Tumour stem cells and drug resistance..Nat Rev Cancer2005;5:275-84

[3] Mansoori B,Davudian S,Baradaran B.The different mechanisms of cancer drug resistance: a brief review..Adv Pharm Bull2017;7:339-48 PMCID:PMC5651054

[4] Dagogo-Jack I.Tumour heterogeneity and resistance to cancer therapies..Nat Rev Clin Oncol2018;15:81-94

[5] Negrini S,Halazonetis TD.Genomic instability--an evolving hallmark of cancer..Nat Rev Mol Cell Biol2010;11:220-8

[6] Chatterjee N.Polytherapy and targeted cancer drug resistance..Trends Cancer2019;5:170-82 PMCID:PMC6446041

[7] Pathania S,Baldi A,Rawal RK.Drug metabolizing enzymes and their inhibitors’ role in cancer resistance..Biomed Pharmacother2018;105:53-65

[8] Calin GA,Shimizu M,Yendamuri S.Familial cancer associated with a polymorphism in ARLTS1..N Engl J Med2005;352:1667-76

[9] Fabbri M.Epigenetics and miRNAs in human cancer..Adv Genet2010;70:87-99

[10] Qu Y,Tan H,Wang N.Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment..Mol Cancer2019;18:69 PMCID:PMC6441162

[11] Elinav E,Thaiss CA,Jin C.Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms..Nat Rev Cancer2013;13:759-71

[12] Fiedler E.Aiding and abetting: how the tumor microenvironment protects cancer from chemotherapy..Ann Rev Cancer Biol2019;3:409-28

[13] Sharma P,Wargo JA.Primary, adaptive, and acquired resistance to cancer immunotherapy..Cell2017;168:707-23 PMCID:PMC5391692

[14] Snyder A,Merghoub T,Zaretsky JM.Genetic basis for clinical response to CTLA-4 blockade in melanoma..N Engl J Med2014;371:2189-99 PMCID:PMC4315319

[15] Rizvi NA,Snyder A,Makarov V.Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer..Science2015;348:124-8 PMCID:PMC4993154

[16] Zaretsky JM,Shin DS,Hugo W.Mutations associated with acquired resistance to PD-1 blockade in melanoma..N Engl J Med2016;375:819-29 PMCID:PMC5007206

[17] Saleh R.Acquired resistance to cancer immunotherapy: role of tumor-mediated immunosuppression..Semin Cancer Biol2019;S1044-579X(19)30171-3

[18] Panebianco C,Pazienza V.Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies..Microbiome2018;6:92 PMCID:PMC5964925

[19] Alexander JL,Teare J,Nicholson JK.Gut microbiota modulation of chemotherapy efficacy and toxicity..Nat Rev Gastroenterol Hepatol2017;14:356-65

[20] Fessler J,Gajewski TF.Exploring the emerging role of the microbiome in cancer immunotherapy..J Immunother Cancer2019;7:108 PMCID:PMC6471869

[21] Li H,Jia W.The influence of gut microbiota on drug metabolism and toxicity..Expert Opin Drug Metab Toxicol2016;12:31-40 PMCID:PMC5683181

[22] Ley RE,Gordon JI.Ecological and evolutionary forces shaping microbial diversity in the human intestine..Cell2006;124:837-48

[23] Lepage P,Joossens M,Blottière HM.A metagenomic insight into our gut’s microbiome..Gut2013;62:146-58

[24] Sender R,Milo R.Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans..Cell2016;164:337-40

[25] Vernocchi P,Putignani L.Gut microbiota profiling: metabolomics based approach to unravel compounds affecting human health..Front Microbiol2016;7:1144 PMCID:PMC4960240

[26] Levy M,Elinav E.Metabolites: messengers between the microbiota and the immune system..Genes Dev2016;30:1589-97 PMCID:PMC4973288

[27] Medzhitov R.Toll-like receptors and innate immunity..Nat Rev Immunol2001;1:135-45

[28] Takeuchi O.Pattern recognition receptors and inflammation..Cell2010;140:805-20

[29] van Niel G,Raposo G.Shedding light on the cell biology of extracellular vesicles..Nat Rev Mol Cell Biol2018;19:213-28

[30] Colombo M,Thery C.Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles..Annu Rev Cell Dev Biol2014;30:255-89

[31] Deatherage BL.Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life..Infect Immun2012;80:1948-57 PMCID:PMC3370574

[32] Peres da Silva R,Rodrigues ML,Joffe LS.Extracellular vesicle-mediated export of fungal RNA..Sci Rep2015;5:7763 PMCID:PMC5379013

[33] Choi DH,Chiura HX,Bae SS.Extracellular Vesicles of the Hyperthermophilic archaeon “thermococcus onnurineus” NA1T..Appl Environ Microbiol2015;81:4591-9 PMCID:PMC4551206

[34] Tsatsaronis JA,Resch U.Extracellular vesicle RNA: a universal mediator of microbial communication?.Trends Microbiol2018;26:401-10

[35] Lee J,Kim SH,Park KS.Staphylococcus aureus extracellular vesicles carry biologically active β-lactamase..Antimicrob Agents Chemother2013;57:2589-95 PMCID:PMC3716153

[36] Ciofu O,Kadurugamuwa J,Høiby N.Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa..J Antimicrob Chemother2000;45:9-13

[37] Rumbo C,Merino M,Mendez JA.Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii..Antimicrob Agents Chemother2011;55:3084-90 PMCID:PMC3122458

[38] Medvedeva ES,Mouzykantov AA,Davydova MN.Adaptation of mycoplasmas to antimicrobial agents: Acholeplasma laidlawii extracellular vesicles mediate the export of ciprofloxacin and a mutant gene related to the antibiotic target..Sci World J2014;2014:150615 PMCID:PMC3925563

[39] Yaron S,Simon L.Vesicle-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria..Appl Environ Microbiol2000;66:4414-20 PMCID:PMC92318

[40] Bitto NJ,Pidot S,Lo C.Bacterial membrane vesicles transport their DNA cargo into host cells..Sci Rep2017;7:7072 PMCID:PMC5539193

[41] Lambertz U,Vasconcelos EJ,Myler PJ.Small RNAs derived from tRNAs and rRNAs are highly enriched in exosomes from both old and new world Leishmania providing evidence for conserved exosomal RNA Packaging..BMC Genomics2015;16:151 PMCID:PMC4352550

[42] Blenkiron C,Muthukaruppan A,Dauros P.Uropathogenic escherichia coli releases extracellular vesicles that are associated with RNA..PLoS One2016;11:e0160440 PMCID:PMC4976981

[43] Sjöström AE,Uhlin BE.Membrane vesicle-mediated release of bacterial RNA..Sci Rep2015;5:15329 PMCID:PMC4612299

[44] Beatty M,Brown E,Chakravarthy U.Small RNAs from plants, bacteria and fungi within the order Hypocreales are ubiquitous in human plasma..BMC Genomics2014;15:933 PMCID:PMC4230795

[45] Wang K,Yuan Y,Zhou Y.The complex exogenous RNA spectra in human plasma: an interface with human gut biota?.PLoS One2012;7:e51009 PMCID:PMC3519536

[46] Stentz R,Jones EJ.Fantastic voyage: the journey of intestinal microbiota-derived microvesicles through the body..Biochem Soc Trans2018;46:1021-7 PMCID:PMC6195637

[47] Choi JW,Cho JH.Tiny RNAs and their voyage via extracellular vesicles: Secretion of bacterial small RNA and eukaryotic microRNA..Exp Biol Med (Maywood)2017;242:1475-81 PMCID:PMC5648287

[48] Ho MH,Goodwin JS,Xie H.Functional Advantages of Porphyromonas gingivalis Vesicles..PLoS One2015;10:e0123448 PMCID:PMC4405273

[49] Kunsmann L,Bauwens A,Glüder M.Virulence from vesicles: Novel mechanisms of host cell injury by Escherichia coli O104:H4 outbreak strain..Sci Rep2015;5:13252 PMCID:PMC4539607

[50] Thay B,Kufer TA,Oscarsson J.Aggregatibacter actinomycetemcomitans outer membrane vesicles are internalized in human host cells and trigger NOD1- and NOD2-dependent NF-kappaB activation..Infect Immun2014;82:4034-46 PMCID:PMC4187862

[51] Koeppen K,Jarek M,Gerber SA.A novel mechanism of host-pathogen interaction through sRNA in bacterial outer membrane vesicles..PLoS Pathog2016;12:e1005672 PMCID:PMC4905634

[52] Choi JW,Hong SH.Secretable small RNAs via outer membrane vesicles in periodontal pathogens..J Dent Res2017;96:458-66

[53] Kim MR,Choi EB,Kim YS.Staphylococcus aureus-derived extracellular vesicles induce neutrophilic pulmonary inflammation via both Th1 and Th17 cell responses..Allergy2012;67:1271-81

[54] Gottesman S.Micros for microbes: non-coding regulatory RNAs in bacteria..Trends Genet2005;21:399-404

[55] Kang SM,Lee Y,Lee HJ.Identification of microRNA-size, small RNAs in Escherichia coli..Curr Microbiol2013;67:609-13

[56] Lee HJ.Analysis of microRNA-size, small RNAs in Streptococcus mutans by deep sequencing..FEMS Microbiol Lett2012;326:131-6

[57] Choi JW,Hong SH.Isolation and characterization of a microRNA-size secretable small RNA in streptococcus sanguinis..Cell Biochem Biophys2018;76:293-301

[58] Han L,Sun Y.Extracellular vesicles in the tumor microenvironment: old stories, but new tales..Mol Cancer2019;18:59 PMCID:PMC6441234

[59] Nauts HC,Coley BL.The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research..Cancer Res1946;6:205-16

[60] Zbar B,Tanaka T.Tumor immunity produced by the intradermal inoculation of living tumor cells and living Mycobacterium bovis (strain BCG)..Science1970;170:1217-8

[61] Aso Y.Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group..Urol Int1992;49:125-9

[62] Iida N,Stewart CA,Bouladoux N.Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment..Science2013;342:967-70 PMCID:PMC6709532

[63] Vétizou M,Daillère R,Waldschmitt N.Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota..Science2015;350:1079-84 PMCID:PMC4721659

[64] Prieto PA,Sherry RM,Kammula US.CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma..Clin Cancer Res2012;18:2039-47 PMCID:PMC3319861

[65] Sivan A,Hubert N,Aquino-Michaels K.Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy..Science2015;350:1084-9 PMCID:PMC4873287

[66] Routy B,Derosa L,Alou MT.Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors..Science2018;359:91-7

[67] Collado MC,Isolauri E,Salminen S.Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly..Appl Environ Microbiol2007;73:7767-70 PMCID:PMC2168041

[68] Matson V,Bao R,Zha Y.The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients..Science2018;359:104-8 PMCID:PMC6707353

[69] Gopalakrishnan V,Nezi L,Andrews MC.Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients..Science2018;359:97-103 PMCID:PMC5827966

[70] Faith JJ,Ridaura VK,Gordon JI.Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice..Sci Transl Med2014;6:220ra11 PMCID:PMC3973144

[71] Mills KH.TLR-dependent T cell activation in autoimmunity..Nat Rev Immunol2011;11:807-22

[72] Franchi L,Viani K.Function of Nod-like receptors in microbial recognition and host defense..Immunol Rev2009;227:106-28 PMCID:PMC2679989

[73] Paulos CM,Kaiser A,Chieppa M.Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling..J Clin Invest2007;117:2197-204 PMCID:PMC1924500

[74] Sun J,Le GW.Distinct immune response induced by peptidoglycan derived from Lactobacillus sp..World J Gastroenterol2005;11:6330-7 PMCID:PMC4320337

[75] Hajam IA,Shahnawaz I,Lee JH.Bacterial flagellin-a potent immunomodulatory agent..Exp Mol Med2017;49:e373 PMCID:PMC5628280

[76] Leleux JA,Roy K.Biophysical attributes of CpG presentation control TLR9 signaling to differentially polarize systemic immune responses..Cell Rep2017;18:700-10

[77] Hall JA,Sun CM,Blank RB.Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses..Immunity2008;29:637-49 PMCID:PMC2712925

[78] Round JL.Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota..Proc Natl Acad Sci U S A2010;107:12204-9 PMCID:PMC2901479

[79] Rooks MG.Gut microbiota, metabolites and host immunity..Nat Rev Immunol2016;16:341-52 PMCID:PMC5541232

[80] Kim CH.Immune regulation by microbiome metabolites..Immunology2018;154:220-9 PMCID:PMC5980225

[81] Smith PM,Panikov N,Gallini CA.The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis..Science2013;341:569-73 PMCID:PMC3807819

[82] Arpaia N,Fan X,van der Veeken J.Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation..Nature2013;504:451-5 PMCID:PMC3869884

[83] Park J,Kang SG,Cooper B.Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway..Mucosal Immunol2015;8:80-93 PMCID:PMC4263689

[84] Furusawa Y,Fukuda S,Nakato G.Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells..Nature2013;504:446-50

[85] Berman D,Siegel J,Weber J.Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma..Cancer Immun2010;10:11 PMCID:PMC2999944

[86] Denning TL,Kronenberg M.Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis..J Immunol2005;174:7487-91

[87] Dubin K,Ren B,Viale A.Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis..Nat Commun2016;7:10391 PMCID:PMC4740747

[88] Raymond E,Woynarowski JM.Oxaliplatin: mechanism of action and antineoplastic activity..Semin Oncol1998;25:4-12

[89] Siddik ZH.Cisplatin: mode of cytotoxic action and molecular basis of resistance..Oncogene2003;22:7265-79

[90] Emadi A,Brodsky RA.Cyclophosphamide and cancer: golden anniversary..Nat Rev Clin Oncol2009;6:638-47

[91] Strauss G,Fischer-Posovszky P,Schanbacher M.4-hydroperoxy-cyclophosphamide mediates caspase-independent T-cell apoptosis involving oxidative stress-induced nuclear relocation of mitochondrial apoptogenic factors AIF and EndoG..Cell Death Differ2008;15:332-43

[92] Schwartz PS.Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells..Mol Pharmacol2001;60:1268-79

[93] Viaud S,Mignot G,Daillère R.The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide..Science2013;342:971-6 PMCID:PMC4048947

[94] Viaud S,Zoubir M,LeCesne A.Cyclophosphamide induces differentiation of Th17 cells in cancer patients..Cancer Res2011;71:661-5

[95] Daillère R,Waldschmitt N,Isnard C.Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects..Immunity2016;45:931-43

[96] Geller LT,Danino T,Shental N.Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine..Science2017;357:1156-60 PMCID:PMC5727343

[97] Masotti A.Interplays between gut microbiota and gene expression regulation by miRNAs..Front Cell Infect Microbiol2012;2:137 PMCID:PMC3487149

[98] Maudet C,Eulalio A.MicroRNAs in the interaction between host and bacterial pathogens..FEBS Lett2014;588:4140-7

[99] Dalmasso G,Yan Y,Charania MA.Microbiota modulate host gene expression via microRNAs..PLoS One2011;6:e19293 PMCID:PMC3084815

[100] Kobayashi M,Ohnuma S,Nakayama K.Wnt-β-catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer..Cancer Sci2016;107:1776-84 PMCID:PMC5198960

[101] Xue X,Yao S,Liu CG.Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40..J Immunol2011;187:5879-86 PMCID:PMC3226774

[102] Mjelle R,Thommesen L,Hofsli E.Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location..BMC Cancer2019;19:161 PMCID:PMC6381638

[103] Yu T,Yu Y,Ma D.Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy..Cell2017;170:548-63.e16 PMCID:PMC5767127

[104] Dorward DW,Judd RC.Export and intercellular transfer of DNA via membrane blebs of Neisseria gonorrhoeae..J Bacteriol1989;171:2499-505 PMCID:PMC209926

[105] Brown L,Prados-Rosales R.Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi..Nat Rev Microbiol2015;13:620-30 PMCID:PMC4860279

[106] Kim JH,Park J.Gram-negative and Gram-positive bacterial extracellular vesicles..Semin Cell Dev Biol2015;40:97-104

[107] Yu YJ,Fan GC.Versatile effects of bacterium-released membrane vesicles on mammalian cells and infectious/inflammatory diseases..Acta Pharmacol Sin2018;39:514-33 PMCID:PMC5888691

[108] Schwechheimer C.Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions..Nat Rev Microbiol2015;13:605-19 PMCID:PMC5308417

[109] Kulp A.Biological functions and biogenesis of secreted bacterial outer membrane vesicles..Annu Rev Microbiol2010;64:163-84 PMCID:PMC3525469

[110] Haurat MF,Rangarajan M,Gray MR.Selective sorting of cargo proteins into bacterial membrane vesicles..J Biol Chem2011;286:1269-76 PMCID:PMC3020734

[111] Ghosal A,Fritz JV,Desai MS.The extracellular RNA complement of Escherichia coli..Microbiologyopen2015;4:252-66 PMCID:PMC4398507

[112] Resch U,Le Rhun A,Rohde M.A Two-component regulatory system impacts extracellular membrane-derived vesicle production in group A streptococcus..MBio2016;7:e00207-16 PMCID:PMC5090034

[113] Liu S,Rezende RM,Wei Z.The host shapes the gut microbiota via fecal microRNA..Cell Host Microbe2016;19:32-43 PMCID:PMC4847146

[114] Azizian A,Kramer F,Bernhardt M.Prognostic value of microRNAs in preoperative treated rectal cancer..Int J Mol Sci2016;17:568 PMCID:PMC4849024

[115] Swanton C.Intratumor heterogeneity: evolution through space and time..Cancer Res2012;72:4875-82 PMCID:PMC3712191

[116] Kreso A,van Galen P,Notta F.Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer..Science2013;339:543-8

[117] Holohan C,Longley DB.Cancer drug resistance: an evolving paradigm..Nat Rev Cancer2013;13:714-26

[118] McMillin DW,Mitsiades CS.The role of tumour-stromal interactions in modifying drug response: challenges and opportunities..Nat Rev Drug Discov2013;12:217-28

[119] Sharma P.Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential..Cell2015;161:205-14 PMCID:PMC5905674

[120] van Vliet MJ,de Bont ES.The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis..PLoS Pathog2010;6:e1000879 PMCID:PMC2877735

[121] Marthey L,Mussini C,Nancey S.Cancer immunotherapy with anti-CTLA-4 monoclonal antibodies induces an inflammatory bowel disease..J Crohns Colitis2016;10:395-401 PMCID:PMC4946758

[122] Chen JH,Lauwers GY.Histopathologic features of colitis due to immunotherapy with anti-PD-1 antibodies..Am J Surg Pathol2017;41:643-54

[123] Ubeda C,Jenq RR,Son T.Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans..J Clin Invest2010;120:4332-41 PMCID:PMC2993598

[124] Teillant A,Barter D,Laxminarayan R.Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study..Lancet Infect Dis2015;15:1429-37

[125] Samet A,Krawczyk B,Nowicki S.Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream..Eur J Clin Microbiol Infect Dis2013;32:1393-400 PMCID:PMC3824565

[126] Tulkens J,Van Deun J,Dhondt B.Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction..Gut2020;69:191-3 PMCID:PMC6943244

[127] Cavaillon JM.Exotoxins and endotoxins: inducers of inflammatory cytokines..Toxicon2018;149:45-53

[128] Zitvogel L,Viaud S,Daillère R.Cancer and the gut microbiota: an unexpected link..Sci Transl Med2015;7:271ps1 PMCID:PMC4690201